Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
23756 | 281 | 45.4 | 91% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ROR ALPHA | Author keyword | 16 | 46% | 9% | 25 |
2 | TH17 CELL DIFFERENTIATION | Author keyword | 9 | 83% | 2% | 5 |
3 | ROR GAMMA | Author keyword | 9 | 59% | 4% | 10 |
4 | RETINOIC ACID RECEPTOR RELATED ORPHAN RECEPTOR | Author keyword | 4 | 67% | 1% | 4 |
5 | UNITS SPIRE GREEN 7 9 | Address | 4 | 75% | 1% | 3 |
6 | NR1F1 | Author keyword | 3 | 100% | 1% | 3 |
7 | RETINOID RELATED ORPHAN RECEPTORS | Author keyword | 3 | 100% | 1% | 3 |
8 | CHEM MOL THER EUT | Address | 2 | 67% | 1% | 2 |
9 | DIPHENYLPROPANAMIDE | Author keyword | 2 | 67% | 1% | 2 |
10 | RETINOID RELATED ORPHAN RECEPTOR GAMMA T | Author keyword | 2 | 67% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | STAGGERER MOUSE | 22 | 66% | 7% | 21 |
2 | AMINO TERMINAL DOMAINS | 16 | 48% | 9% | 24 |
3 | ROR ALPHA | 12 | 24% | 16% | 45 |
4 | ORPHAN RECEPTOR ALPHA | 12 | 63% | 4% | 12 |
5 | STAGGERER MICE | 7 | 57% | 3% | 8 |
6 | ROR ALPHA 1 | 6 | 100% | 1% | 4 |
7 | STAGGERER | 6 | 33% | 5% | 14 |
8 | STAGGERER MUTANT MICE | 2 | 23% | 3% | 9 |
9 | CIRCADIAN TRANSCRIPTION | 2 | 24% | 3% | 8 |
10 | ORPHAN RECEPTOR SUBFAMILY | 2 | 67% | 1% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
ROR nuclear receptors: structures, related diseases, and drug discovery | 2015 | 2 | 89 | 49% |
Action of RORs and their ligands in (patho)physiology | 2012 | 34 | 60 | 47% |
REV-ERB and ROR nuclear receptors as drug targets | 2014 | 24 | 134 | 31% |
Synthetic modulators of the retinoic acid receptor-related orphan receptors | 2013 | 8 | 51 | 71% |
Small molecule inhibitors of ROR gamma t: Targeting Th17 cells and other applications | 2012 | 37 | 41 | 22% |
ROR alpha in genetic control of cerebellum development: 50 staggering years | 2007 | 38 | 42 | 43% |
Targeting Orphan Nuclear Receptors for Treatment of Metabolic Diseases and Autoimmunity | 2012 | 23 | 78 | 29% |
Inhibiting ROR gamma t/Th17 axis for autoimmune disorders | 2014 | 9 | 46 | 33% |
Targeting the Nuclear Hormone Receptor ROR gamma t for the Treatment of Autoimmune and Inflammatory Disorders | 2013 | 8 | 47 | 38% |
Retinoid-related orphan receptor alpha and the regulation of lipid homeostasis | 2012 | 5 | 95 | 58% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | UNITS SPIRE GREEN 7 9 | 4 | 75% | 1.1% | 3 |
2 | CHEM MOL THER EUT | 2 | 67% | 0.7% | 2 |
3 | FRE 3210 | 1 | 100% | 0.7% | 2 |
4 | DVSN | 1 | 33% | 1.1% | 3 |
5 | UMR 7102 NPA | 1 | 40% | 0.7% | 2 |
6 | CNRS UPR 9078 | 1 | 33% | 0.7% | 2 |
7 | EARLY DISCOVERY | 1 | 33% | 0.7% | 2 |
8 | CELL BIOL SECT INTRAMURAL | 1 | 50% | 0.4% | 1 |
9 | FEDERATIF RECH 141 | 1 | 50% | 0.4% | 1 |
10 | GENET MOL NEUROTRANSMISS PROC | 1 | 50% | 0.4% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000258149 | TR4//GERM CELL NUCLEAR FACTOR//GCNF |
2 | 0.0000159613 | ZEBRIN II//PURKINJE CELL//ZEBRIN |
3 | 0.0000129542 | CLOCK GENES//CLOCK GENE//BMAL1 |
4 | 0.0000114594 | NUR77//NURR1//NGFI B |
5 | 0.0000113771 | LIVER X RECEPTOR//LXR//LIVER X RECEPTORS |
6 | 0.0000112550 | RETINOYLATION//RETINOBENZOIC ACID//RXR |
7 | 0.0000094474 | IL 17//INTERLEUKIN 17//TH17 |
8 | 0.0000089695 | AIB1//STEROID HORMONES SECT//RIP140 |
9 | 0.0000066046 | CHRONONEUROENDOCRINE ONCOL//CIRCADIAN DISRUPTION//LIGHT AT NIGHT |
10 | 0.0000052363 | RESISTANCE TO THYROID HORMONE//THYROID HORMONE RECEPTOR//V ERBA |